Intranasal insulin neuroprotection in ischemic stroke

Neural Regeneration Research

Volumn 11, Issue 3, 2016, Pages 400-401

  Lioutas, Vasileios Arsenios ^a   Novak, Vera ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; INSULIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ALZHEIMER DISEASE; APOPTOSIS; BLOOD BRAIN BARRIER; BLOOD CLOT LYSIS; BRAIN FUNCTION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; EXCITOTOXICITY; HUMAN; HYPOGLYCEMIA; HYPOTHERMIA; INFLAMMATION; MILD COGNITIVE IMPAIRMENT; NERVE CELL PLASTICITY; NERVE REGENERATION; NEUROPROTECTION; NEUROTRANSMISSION; NOTE; PHASE 1 CLINICAL TRIAL (TOPIC); PLEIOTROPY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

EID: 84962198374     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.4103/1673-5374.179040     Document Type: Note

References (12)

1. Albers GW, Goldstein LB, Hess DC, Wechsler LR, Furie KL, Gorelick PB, Hurn P, Liebeskind DS, Nogueira RG, Saver JL (2011) Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies. Stroke 42:2645-2650.
2. Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, Schonewille WJ, Vos JA, Nederkoorn PJ, Wermer MJ, van Walderveen MA, Staals J, Hofmeijer J, van Oostayen JA, Lycklama à Nijeholt GJ, Boiten J, Brouwer PA, Emmer BJ, de Bruijn SF, van Dijk LC, et al. (2015) A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 372:11-20.
3. Craft S, Baker LD, Montine TJ, Minoshima S, Watson GS, Claxton A, Arbuckle M, Callaghan M, Tsai E, Plymate SR, Green PS, Leverenz J, Cross D, Gerton B (2012) Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol 69:29-38.
4. Duarte AI, Moreira PI, Oliveira CR (2012) Insulin in central nervous system: more than just a peripheral hormone. J Aging Res 2012:384017.
5. Garg R, Chaudhuri A, Munschauer F, Dandona P (2006) Hyperglycemia, insulin, and acute ischemic stroke: a mechanistic justification for a trial of insulin infusion therapy. Stroke 37:267-273.
6. Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, Roy D, Jovin TG, Willinsky RA, Sapkota BL, Dowlatshahi D, Frei DF, Kamal NR, Montanera WJ, Poppe AY, Ryckborst KJ, Silver FL, Shuaib A, Tampieri D, Williams D, et al. (2015) Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 372:1019-1030.
7. Huang SS, Lu YJ, Huang JP, Wu YT, Day YJ, Hung LM (2014) The essential role of endothelial nitric oxide synthase activation in insulin-mediated neuroprotection against ischemic stroke in diabetes. J Vasc Surg 59:483-491.
8. Lioutas VA, Alfaro-Martinez F, Bedoya F, Chung CC, Pimentel DA, Novak V (2015) Intranasal insulin and insulin-like growth factor 1 as neuroprotectants in acute ischemic stroke. Transl Stroke Res 6:264-275.
9. Liu XF, Fawcett JR, Thorne RG, Frey WH, 2nd (2001) Non-invasive intranasal insulin-like growth factor-I reduces infarct volume and improves neurologic function in rats following middle cerebral artery occlusion. Neurosci Lett 308:91-94.
10. Lochhead JJ, Thorne RG (2012) Intranasal delivery of biologics to the central nervous system. Adv Drug Deliv Rev 64:614-628.
11. Reger MA, Watson GS, Green PS, Baker LD, Cholerton B, Fishel MA, Plymate SR, Cherrier MM, Schellenberg GD, Frey WH, 2nd, Craft S (2008) Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults. J Alzheimers Dis 13:323-331.
12. Thorne RG, Pronk GJ, Padmanabhan V, Frey WH, 2nd (2004) Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience 127:481-496.